Takahiro Kishikawa

3.3k total citations · 1 hit paper
65 papers, 2.8k citations indexed

About

Takahiro Kishikawa is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Takahiro Kishikawa has authored 65 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Cancer Research and 16 papers in Epidemiology. Recurrent topics in Takahiro Kishikawa's work include MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (13 papers) and RNA modifications and cancer (11 papers). Takahiro Kishikawa is often cited by papers focused on MicroRNA in disease regulation (26 papers), Cancer-related molecular mechanisms research (13 papers) and RNA modifications and cancer (11 papers). Takahiro Kishikawa collaborates with scholars based in Japan, United States and China. Takahiro Kishikawa's co-authors include Motoyuki Otsuka, Kazuhiko Koike, Takeshi Yoshikawa, Akemi Takata, Haruhiko Yoshida, Kentaro Kojima, Young Jun Kang, Masao Akanuma, Masao Omata and Motoko Ohno and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Takahiro Kishikawa

60 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma

2012 1.2k citations Kentaro Kojima, Akemi Takata et al. Nature Communications profile →

Peers

Countries citing papers authored by Takahiro Kishikawa

Since Specialization

Citations

This map shows the geographic impact of Takahiro Kishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Kishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Kishikawa more than expected).

Fields of papers citing papers by Takahiro Kishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Kishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Kishikawa. The network helps show where Takahiro Kishikawa may publish in the future.

Co-authorship network of co-authors of Takahiro Kishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Kishikawa. A scholar is included among the top collaborators of Takahiro Kishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Kishikawa. Takahiro Kishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment 2025 ·Scientific Reports ·(unknown), (unknown), Makoto Sano, (unknown), Koji Miyabayashi, R Takahashi, Takahiro Kishikawa, (unknown)	0
2	Modeling intestinal epithelial function and polarity using human iPSCs under Air–Liquid interface culture 2025 ·Biochemical and Biophysical Research Communications ·Eri Tanaka, Takahiro Kishikawa, (unknown), Chikako Shibata, (unknown), (unknown), Takahiro Seimiya, Motoyuki Otsuka, Mitsuhiro Fujishiro	0
3	Satellite double-stranded RNA induces mesenchymal transition in pancreatic cancer by regulating alternative splicing 2024 ·Journal of Biological Chemistry ·(unknown), Takahiro Kishikawa, Takahiro Seimiya, (unknown), Tatsunori Suzuki, Chikako Shibata, (unknown), (unknown), (unknown), Eri Tanaka, Mari Yamagami, Kazuma Sekiba, Motoyuki Otsuka, Kazuhiko Koike, Mitsuhiro Fujishiro	2
4	CA19-9-Positive Extracellular Vesicle Is a Risk Factor for Cancer-Associated Thrombosis in Pancreatic Cancer 2024 ·SHILAP Revista de lepidopterología ·Chikako Shibata, Motoyuki Otsuka, Kazunaga Ishigaki, Takahiro Seimiya, Takahiro Kishikawa, Mitsuhiro Fujishiro	3
5	Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells 2024 ·Cellular and Molecular Gastroenterology and Hepatology ·(unknown), Motoyuki Otsuka, Chikako Shibata, Takahiro Seimiya, Keisuke Yamamoto, Rei Ishibashi, Takahiro Kishikawa, Eri Tanaka, Takayuki Isagawa, Norihiko Takeda, Noriaki Kamio, Kenichi Imai, Mitsuhiro Fujishiro	15
6	Combination of serum human satellite RNA and miR-21-5p levels as a biomarker for pancreatic cancer 2023 ·iScience ·Takahiro Seimiya, Tatsunori Suzuki, (unknown), Takahiro Kishikawa, Kazuma Sekiba, Chikako Shibata, Kazunaga Ishigaki, Hiroaki Fujiwara, Hiroki Oyama, Sachiko Kanai, Tatsuya Sato, Yousuke Nakai, Rei Ishibashi, Masaru Moriyama, Ryo Nakagawa, Hideaki Ijichi, Motoyuki Otsuka, Kazuhiko Koike	5
7	Increased expression of TNFRSF14 and LIGHT in biliary epithelial cells of patients with primary sclerosing cholangitis 2023 ·Digestive and Liver Disease ·Sachiko Kanai, Hiroaki Fujiwara, Shugo Mizuno, Takahiro Kishikawa, T. Nakatsuka, Tsuyoshi Hamada, Mariko Tanaka, Junichi Arita, Yousuke Nakai, Hiroyuki Isayama, Masato Kasuga, Ryosuke Tateishi, Keisuke Tateishi, Tetsuo Ushiku, Kiyoshi Hasegawa, Kazuhiko Koike, Mitsuhiro Fujishiro	0
8	Post-treatment cell-free DNA as a predictive biomarker in molecular-targeted therapy of hepatocellular carcinoma 2021 ·Journal of Gastroenterology ·T. Nakatsuka, Hayato Nakagawa, Yuki Hayata, (unknown), Tomoharu Yamada, (unknown), Ryo Nakagomi, Masaya Sato, Tatsuya Minami, Koji Uchino, Kenichiro Enooku, Yotaro Kudo, Yasuo Tanaka, Takahiro Kishikawa, Motoyuki Otsuka, Ryosuke Tateishi, Kazuhiko Koike	19
9	Satellite RNA Increases DNA Damage and Accelerates Tumor Formation in Mouse Models of Pancreatic Cancer 2018 ·Molecular Cancer Research ·Takahiro Kishikawa, Motoyuki Otsuka, Tatsunori Suzuki, Takahiro Seimiya, Kazuma Sekiba, Rei Ishibashi, Eri Tanaka, Motoko Ohno, Mari Yamagami, Kazuhiko Koike	11
10	A phase II trial of gemcitabine, S-1 and LV combination (GSL) therapy in patients with advanced pancreatic cancer 2018 ·Investigational New Drugs ·Kei Saito, Hiroyuki Isayama, Yousuke Nakai, Naminatsu Takahara, Kazunaga Ishigaki, Tsuyoshi Takeda, Ryunosuke Hakuta, Tomotaka Saito, Rie Uchino, Takahiro Kishikawa, Tsuyoshi Hamada, Suguru Mizuno, Takashi Sasaki, Hirofumi Kogure, Saburo Matsubara, Natsuyo Yamamoto, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada, Kazuhiko Koike	5
11	Transcriptional activation of the MICA gene with an engineered CRISPR-Cas9 system 2017 ·Biochemical and Biophysical Research Communications ·Kazuma Sekiba, Mari Yamagami, Motoyuki Otsuka, Tatsunori Suzuki, Takahiro Kishikawa, Rei Ishibashi, Motoko Ohno, Masaya Sato, Kazuhiko Koike	17
12	Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7 2016 ·Scientific Reports ·Akemi Takata, Motoyuki Otsuka, Motoko Ohno, Takahiro Kishikawa, Takeshi Yoshikawa, Kazuhiko Koike	25
13	Circulating RNAs as new biomarkers for detecting pancreatic cancer 2015 ·World Journal of Gastroenterology ·Takahiro Kishikawa	125
14	The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels 2014 ·Virology ·Chikako Shibata, Motoko Ohno, Motoyuki Otsuka, Takahiro Kishikawa, Kaku Goto, Ryosuke Muroyama, Naoya Kato, Takeshi Yoshikawa, Akemi Takata, Kazuhiko Koike	99
15	Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs 2013 ·Scientific Reports ·Takahiro Kishikawa, Motoyuki Otsuka, Takeshi Yoshikawa, Motoko Ohno, Akemi Takata, Chikako Shibata, Yuji Kondo, Masao Akanuma, Haruhiko Yoshida, Kazuhiko Koike	39
16	Inhibition of microRNA122 decreases SREBP1 expression by modulating suppressor of cytokine signaling 3 expression 2013 ·Biochemical and Biophysical Research Communications ·Chikako Shibata, Takahiro Kishikawa, Motoyuki Otsuka, Motoko Ohno, Takeshi Yoshikawa, Akemi Takata, Haruhiko Yoshida, Kazuhiko Koike	17
17	MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression 2012 ·Hepatology ·Akemi Takata, Motoyuki Otsuka, Takeshi Yoshikawa, Takahiro Kishikawa, Yohko Hikiba, Shuntaro Obi, Tadashi Goto, Young Jun Kang, Shin Maeda, Haruhiko Yoshida, Masao Omata, Hiroshi Asahara, Kazuhiko Koike	85
18	A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function 2012 ·Biochemical and Biophysical Research Communications ·Akemi Takata, Motoyuki Otsuka, Takeshi Yoshikawa, Takahiro Kishikawa, Yotaro Kudo, Tadashi Goto, Haruhiko Yoshida, Kazuhiko Koike	26
19	Receptor for Activated Protein Kinase C: Requirement for Efficient MicroRNA Function and Reduced Expression in Hepatocellular Carcinoma 2011 ·PLoS ONE ·Motoyuki Otsuka, Akemi Takata, Takeshi Yoshikawa, Kentaro Kojima, Takahiro Kishikawa, Chikako Shibata, Mutsuhiro Takekawa, Haruhiko Yoshida, Masao Omata, Kazuhiko Koike	21
20	MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma 2011 ·Nature Communications ·Kentaro Kojima, Akemi Takata, Charles Vadnais, Motoyuki Otsuka, Takeshi Yoshikawa, Masao Akanuma, Yuji Kondo, Young Jun Kang, Takahiro Kishikawa, Naoya Kato, Zhifang Xie, Weiping J. Zhang, Haruhiko Yoshida, Masao Omata, Alain Nepveu, Kazuhiko Koike	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact